Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:KemPharm
|
| gptkbp:CEO |
gptkb:Anders_Vadsholt
|
| gptkbp:country |
gptkb:Denmark
|
| gptkbp:filedForBankruptcy |
2022
|
| gptkbp:focus |
rare diseases
protein misfolding diseases |
| gptkbp:founded |
2009
|
| gptkbp:founder |
gptkb:Anders_Hinsby
gptkb:Thomas_Kirkegaard |
| gptkbp:headquartersLocation |
gptkb:Copenhagen,_Denmark
|
| https://www.w3.org/2000/01/rdf-schema#label |
Orphazyme
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:Nasdaq_Copenhagen
|
| gptkbp:notableProduct |
gptkb:arimoclomol
|
| gptkbp:website |
https://www.orphazyme.com/
|
| gptkbp:bfsParent |
gptkb:Sunstone_Life_Science_Ventures
|
| gptkbp:bfsLayer |
7
|